The sensitivity of methylation detection exhibited an increasing trend with TNM progression, with values of 69.70% (95% CI: 51.13%−83.79%) in stage I and 91.18% (95% CI: 75.19%−97.69%) in stage II.
← all excerpts
The aMAP score combined with plasma cfDNA methylation testing for risk stratification in hepatitis population: a case-control study.
1
—
—